3.84BMarket Cap-12.53P/E (TTM)
35.900High34.480Low2.18MVolume35.200Open33.910Pre Close76.96MTurnover2.18%Turnover RatioLossP/E (Static)109.43MShares36.60052wk High5.75P/B3.51BFloat Cap13.48052wk Low--Dividend TTM100.04MShs Float193.540Historical High--Div YieldTTM4.19%Amplitude13.480Historical Low35.235Avg Price1Lot Size
Zai Lab Stock Forum
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) has received Orphan Drug Designation (ODD) from the U.S. FDA for ZL-1310, their first-in-class DLL3 antibody-drug conjugate (ADC) designed to treat small cell lung cancer (SCLC). The designation comes after promising results from an ongoing Phase 1a/1b study in patients with previously treated extensive-stage SCL...
No comment yet